Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system
Authors:
- 29 October 2015
- journal article
- research article
- Published by Taylor & Francis in Infectious Diseases
- Vol. 48 (2) , 161-166
Abstract
(2016). Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system. Infectious Diseases: Vol. 48, No. 2, pp. 161-166. doi: 10.3109/23744235.2015.1100322Keywords
This publication has 15 references indexed in Scilit:
- ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic proceduresClinical Microbiology and Infection, 2012
- Cytomegalovirus Infection After Liver Transplantation: Prophylaxis and Preemptive Treatment—A Single-Center ExperienceTransplantation Proceedings, 2010
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) DatabaseClinical Infectious Diseases, 2010
- Candida in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2009
- Antifungal prophylaxis in liver transplant recipientsLiver Transplantation, 2009
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant RecipientsTransplantation, 2009
- Outcomes of antifungal prophylaxis in high‐risk liver transplant recipientsTransplant Infectious Disease, 2009
- Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled studyTransplant International, 2002
- Oral mycoses in HIV infectionOral Surgery, Oral Medicine, Oral Pathology, 1992